Leaflet PROPAFENONA ARENA 150mg tablets


Indicated for: cardiac arrhythmias

Substance: propafenone (antiarrhythmic)

ATC: C01BC03 (Cardiovascular system | Antiarrhythmics, class I and III | Antiarrhythmics, class Ic)

Propafenone is a medication used to treat cardiac arrhythmias, such as atrial fibrillation or ventricular tachycardia. It belongs to the class Ic antiarrhythmics and works by slowing the conduction of electrical impulses in the heart, restoring normal heart rhythm.

The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to monitor cardiac function during treatment to prevent complications.

Side effects may include dizziness, nausea, constipation, or fatigue. In rare cases, severe adverse effects such as worsening arrhythmias or heart failure may occur, requiring immediate medical attention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as heart or liver diseases, to ensure the safe use of propafenone.

General data about PROPAFENONA ARENA 150mg

  • Substance: propafenone
  • Date of last drug list: 01-05-2026
  • Commercial code: W56891004
  • Concentration: 150mg
  • Pharmaceutical form: tablets
  • Quantity: 100
  • Product type: generic
  • Price: 43.02 RON
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: ARENA GROUP S.A. - ROMANIA
  • Holder: ARENA GROUP S.A. - ROMANIA
  • Number: 12263/2019/03
  • Shelf life: 3 years

Concentrations available for propafenone

  • 150mg
  • 300mg
  • 35mg/10ml
  • 70mg/20ml

Compensation lists for PROPAFENONA ARENA 150mg Arena

A - Sublist A with 90% discount from the reference price

Price

Copayment

Patient

43.02 RON

38.72 RON

4.30 RON